Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …

Background and Purpose— This scientific statement provides an overview of the evidence
on vascular contributions to cognitive impairment and dementia. Vascular contributions to …

Objective To examine the prevalence of mild cognitive impairment (MCI) and its diagnostic
classification in the Cardiovascular Health Study (CHS) Cognition Study. Design The CHS …

The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …

The Neuropsychiatric Inventory (NPI) is a validated clinical instrument for evaluating
psychopathology in dementia. The authors developed a brief questionnaire form of the NPI (NPI-Q), …

Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM,
and CR1 as novel genes for late-onset Alzheimer disease (AD). Objectives To identify and …

Dementia with Lewy bodies (DLB) is the second commonest cause of neurodegenerative
dementia in older people. It is part of the range of clinical presentations that share a neuritic …

We identified rare coding variants associated with Alzheimer's disease in a three-stage case–control
study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-…

Context Ginkgo biloba is widely used for its potential effects on memory and cognition. To
date, adequately powered clinical trials testing the effect of G biloba on dementia incidence …

Physical activity may help preserve cognitive function and decrease dementia risk, but
epidemiologic findings are inconsistent. The authors conducted a prospective study to determine …